NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

It matters because of what I had suggested in my removed posts, that is that perhaps this funding deal needed to occur before results are announced. Why?

"The shares are also subject to a voting agreement, under which the investors have agreed to vote in support of such increase in authorized shares"

Well, as far as I understand the prior Cognate deal requires shareholder approval because it requires more shares than are available be issued. This deal requires investors to vote for a share increase. Perhaps, there were no longer enough friendly votes to see the deal go through at such advantageous pricing. They need each other now.

As far as those speculating the end is not imminent, I say this... Treatment in studies alomost always continues until data is reported and usually for much longer afterwards in an extension trial. The statement about treatment say nothing about data readout. Again, the Feb PR laid out an expectation on timing. The June presentation further narrowed that expectation. The result of these is that one should reasonablly expect results have either been viewed or will be viewed by management in the coming few weeks. The Sept 8k, reinforces this "anticipated" timing. Any change in this requires a clear PR or SEC filing as to the change in expectations.

Results are pending any day now. AND we have been diluted to oblivion in the past month. shame! Shame! Shame!